Redefining microbiome-based therapeutics MRM Health NV is a biopharmaceutical company focused on the discovery and development of innovative therapeutics based on the human microbiome.The company is based in a Center of Expertise for microbiome research and development in the biotech cluster in Ghent, Belgium, and has a strategic partnership with the VIB, with top research groups in both microbiome analysis and ecology and in host biology and disease research. The Company is strategically supported by strong local and international investors, including Ackermans & van Haaren, DuPont, MRM Technologies, Qbic II and VIB and has a corporate collaboration with DuPont Nutrition …

75 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Unlocking biology using mathematics At Biomathematica, we believe mathematics has the power to revolutionize biology. We have developed a Systems Biology approach to characterize, predict, engineer, control and optimize simple and complex microbial communities. We use this technology for: -The development of probiotics / prebiotics / synbiotics and live biotherapeutics targeting the human microbiome. -The engineering of bacterial strains or consortia targeting the animal, environmental and artificial microbiome(s). -The design of new metabolic pathways involving several bacterial or unicellular strains. -Other bioinformatics services such as Shotgun Metagenomic data analysis, Strain level resolution for bacteria, virus, fungi, protists (WGS), Gene characterization …

19 similar entities Type: Startup Activities: deeptech healthtech biotech Technologies: Data Analytics

Casting light on the microbiome We founded mbiomics to improve peoples lives by providing a novel approach to fully understand the secrets of the microbiome with the goal to better inform targeted therapies and how to lead a healthy life. microbiome, precision medicine, biotechnology, diagnostics, immuno-oncology, and companion diagnostics

70 similar entities Type: Startup Activities: deeptech biotech

Initially built out of 10 years investment in the Wellcome Sanger Institute, Microbiotica has unrivalled capabilities in microbiome analysis linked to patient phenotype. It is a global leader in gut bacterial culturing, and has a world leading microbiome Culture Collection, proprietary Reference Genome Database and advanced microbiome bioinformatics. The company also has advanced capabilities in microbiome/host biology and preclinical development of bacterial products. Microbiotica has a pipeline of highly differentiated clinically-derived products including Live Bacterial Therapeutics and Biomarkers in IBD, Immuno-oncology and Gut Epithelial Barrier Repair. It has collaborations with Cancer Research UK and Cambridge University Hospitals in Immuno-oncology, Genentech/Roche …

63 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Part of Cmbio Eagle Genomics applies network science to biology. We are revealing the impact of the microbiome on humans, animals and the environment to secure a sustainable future for our food, water, soil and the health of our planet. Our mission is to deliver insight from the microbiome to profoundly change our understanding of wellness and even our fundamental assumptions about life on earth. Our platform transforms scientists’ journey to insights, unifying constellations of complex, multi-dimensional data (the data fabric) to explore and extract signals and networks of relationship, otherwise not detectable by humans alone. This is the frontier …

10 similar entities Type: Startup Activities: deeptech biotech it services Technologies: Data Analytics